(Q81918606)

English

A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes

scientific article published on 01 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

attenuated vaccine

1 reference

based on heuristic

inferred from title

measles vaccine

1 reference

based on heuristic

inferred from title

author name string

Clarisse Lorin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Frédéric Delebecque

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Valérie Labrousse

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Lucie Da Silva

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

François Lemonnier

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Michel Brahic

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Frédéric Tangy

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 August 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

4463-4472

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Immunologic control of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Prospects for vaccine protection against HIV-1 infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Immunopathogenesis and immunotherapy in AIDS virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

HIV vaccine design and the neutralizing antibody problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

HIV-1 Reverse Transcription A Termination Step at the Center of the Genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Viral persistence: HIV's strategies of immune system evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

HIV escape: there and back again

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Immunology. CD8 T cells remember with a little help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Measles virus induces functional TRAIL production by human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Reverse Genetics Meets the Nonsegmented Negative-Strand RNA Viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

A recombinant measles virus expressing biologically active human interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.024

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.04.024

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993518%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81918606&oldid=1565441592"